SpaceX shares trade at $151 ahead of a pivotal Starship orbital test, with management targeting $1 trillion in annual revenue by 2030 following strong Q2 growth.
SpaceX stock is treated as a bullish catalyst play ahead of the planned Starship orbital test and Starlink V3 deployment, supported by strong Q2 growth and an accelerated $1 trillion revenue target.
SpaceX (SPCX) stock gains momentum as the company prepares for its 14th Starship flight on September 22. The mission aims to achieve orbit and deploy Starlink V3 satellites, marking a critical milestone for the firm's growth strategy. With Q2 revenue surging 92% and an accelerated $1 trillion annual revenue target by 2030, investors are closely watching the technical progress of the launch vehicle.
The flight is a critical catalyst because it aims to achieve orbit and deploy high-capacity Starlink V3 satellites, validating the company's path toward routine reuse and long-term revenue growth.